The Laboratory for Bio-Micro Devices at Brigham and Women’s Hospital () develops drug releasing implantable intratumoral microdevices (IMD) [1]. Using MIKAIA®, they want to examine in a quantitative fashion how the cell subpopulations change...
Volker Bruns
Christian Weigand
Anna Chiwona
Topics
Latest Posts
High Content Imaging: Analyzing Ex-Vivo Drug Response Assays with MIKAIA
Researchers at the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) have developed PEDRA: Platform for Ex-Vivo Drug Response Assays. Up to 100 compounds are tested in parallel on primary patient...
Size Matters. — How much Data does a Digital Pathologist actually Generate?
It’s 2025 and a growing number of pathologists is already convinced, that going digital is worth it. (If you’re still on the fence, read our Ultimate Guide: 10 Things You Should Know about the Transformational Impact of...
Acquiring Multimodal Data in the Driving Simulator
To advance the development of innovative driver monitoring systems, it is essential to acquire multimodal data that includes driving behavior, driver states, well-being, and cognitive load. However, to achieve high...
Proximity Analysis: Quantifying Cell Subpopulations in Vicinity of Intratumoral Microdevice (IMD)
The Laboratory for Bio-Micro Devices at Brigham and Women’s Hospital () develops drug releasing implantable intratumoral microdevices (IMD) [1]. Using MIKAIA®, they want to examine in a quantitative fashion how...
